Crestline Management, LP
- SEC CIK
- 0001536054
- Latest filing
- Aug 14, 2026
PBYI holding history
Puma Biotechnology, Inc. in every 13F filed by Crestline Management, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PBYI overviewAll 13F holders of PBYIFull Q2 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −35,832−100.0% | Sold out | Holders |
| Q1 2024 | 35,832 | $189.9K | <0.1% | +1,058+3.0% | Added | Holders |
| Q4 2023 | 34,774 | $150.6K | <0.1% | +2,135+6.5% | Added | Holders |
| Q3 2023 | 32,639 | $85.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 32,639 | $115.2K | <0.1% | +755+2.4% | Added | Holders |
| Q1 2023 | 31,884 | $98.5K | <0.1% | +3,388+11.9% | Added | Holders |
| Q4 2022 | 28,496 | $120.5K | <0.1% | +291+1.0% | Added | Holders |
| Q3 2022 | 28,205 | $67.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 28,205 | $80.0K | <0.1% | −366−1.3% | Reduced | Holders |
| Q1 2022 | 28,571 | $82.0K | <0.1% | +28,571 | New | Holders |